{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T02:33:47Z","timestamp":1648866827885},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T00:00:00Z","timestamp":1047427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s00108-003-0882-z","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T21:49:41Z","timestamp":1476740981000},"page":"633-642","source":"Crossref","is-referenced-by-count":0,"title":["Therapie von Tropenkrankheiten bei Reiser\u00fcckkehrern"],"prefix":"10.1007","volume":"44","author":[{"given":"G. D.","family":"Burchard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Sudeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,3,12]]},"reference":[{"key":"0882_CR1","doi-asserted-by":"crossref","unstructured":"Albanese G, Venturi C, Galbiati G (2001) Treatment of larva migrans cutanea (creeping eruption): a comparison between albendazole and traditional therapy. Int J Dermatol 40: 67\u201371","DOI":"10.1046\/j.1365-4362.2001.01103.x"},{"key":"0882_CR2","doi-asserted-by":"crossref","unstructured":"Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH (2002) Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 346: 891\u2013895","DOI":"10.1056\/NEJMoa011882"},{"key":"0882_CR3","doi-asserted-by":"crossref","unstructured":"Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, Kelly P (2002) Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 360: 1375\u20131380","DOI":"10.1016\/S0140-6736(02)11401-2"},{"key":"0882_CR4","doi-asserted-by":"crossref","unstructured":"Arana BA, Mendoza CE, Rizzo NR, Kr\u00f6ger A (2001) Randomized, controlled, double\u2013blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. Am J Trop Med Hyg 65: 466\u2013470","DOI":"10.4269\/ajtmh.2001.65.466"},{"key":"0882_CR5","unstructured":"Bhatia S, Karnad DR, Oak JL (1998) Randomized double-blind trial of metronidazole versus secnidazole in amebic liver abscess. Indian J Gastroenterol 17: 53\u201354"},{"key":"0882_CR6","unstructured":"Bialek R, Knobloch J (1999) Parasit\u00e4re Infektionen in der Schwangerschaft und konnatale Parasitosen. I. Teil: Protozoeninfektionen. Z Geburtsh Neonatol 203: 55\u201362"},{"key":"0882_CR7","unstructured":"Bialek R, Knobloch J (1999) Parasit\u00e4re Infektionen in der Schwangerschaft und konnatale Parasitosen. II. Teil: Helmintheninfektionen. Z Geburtsh Neonatol 203: 128\u2013133"},{"key":"0882_CR8","doi-asserted-by":"crossref","unstructured":"Blessmann J, Tannich E (2002) Treatment of asymptomatic intestinal Entamoeba histolytica infection. N Engl J Med 347: 1384","DOI":"10.1056\/NEJM200210243471722"},{"key":"0882_CR9","doi-asserted-by":"crossref","unstructured":"Bouchaud O, Houze S, Schiemann R, Durand R, Ralaimazava P, Ruggeri C, Coulaud JP (2000) Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin. Clin Infect Dis 31: 493\u2013498","DOI":"10.1086\/313942"},{"key":"0882_CR10","doi-asserted-by":"crossref","unstructured":"Burchard GD (1999) Fieber nach Tropenaufenthalt. Internist 40: 1143\u20131149","DOI":"10.1007\/s001080050450"},{"key":"0882_CR11","doi-asserted-by":"crossref","unstructured":"Bustos DG, Canfield CJ, Canete-Miguel E, Hutchinson DB (1999) Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines. J Infect Dis 179: 1587\u20131590","DOI":"10.1086\/314770"},{"key":"0882_CR12","doi-asserted-by":"crossref","unstructured":"Caumes E, Carriere J, Datry A, Gaxotte P, Danis M, Gentilini M (1993) A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg 49: 641\u2013644","DOI":"10.4269\/ajtmh.1993.49.641"},{"key":"0882_CR13","doi-asserted-by":"crossref","unstructured":"Caumes E, Carriere J, Guermonprez G, Bricaire F, Danis M, Gentilini M (1995) Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin Infect Dis 20: 542\u2013548","DOI":"10.1093\/clinids\/20.3.542"},{"key":"0882_CR14","unstructured":"Cesari J, Condat M, Gendron Y, Saint-Andre P, Thomas J, Charmot G (1982) Treatment of amibiasis with short-term secnidazole therapy. Med Trop (Mars) 42: 527\u2013530"},{"key":"0882_CR15","doi-asserted-by":"crossref","unstructured":"Chapman SW, Bradsher RW, Campbell GD, Pappas PG, Kauffman CA (2000) Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis 30: 679\u2013683","DOI":"10.1086\/313750"},{"key":"0882_CR16","unstructured":"Chunge CN, Estambale BB, Pamba HO, Chitayi PM, Munanga PN, Kang'ethe S (1989) Comparison of four nitroimidazole compounds for treatment of symptomatic amoebiasis in Kenya. East Afr Med J 66: 724\u2013727"},{"key":"0882_CR17","doi-asserted-by":"crossref","unstructured":"Coukell AJ, Brogden RN (1998) Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis. Drugs 55: 585\u2013612","DOI":"10.2165\/00003495-199855040-00008"},{"key":"0882_CR18","doi-asserted-by":"crossref","unstructured":"da Cunha AS, Pedrosa RC (1986) Double-blind therapeutical evaluation based on the quantitative oogram technique, comparing praziquantel and oxamniquine in human schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 28: 337\u2013351","DOI":"10.1590\/S0036-46651986000500009"},{"key":"0882_CR19","unstructured":"de la Rey Nel J, Simjee AE, Patel A (1989) Indications for aspiration of amoebic liver abscess. S Afr Med J 75: 373\u2013376"},{"key":"0882_CR20","doi-asserted-by":"crossref","unstructured":"de Silva N, Guyatt H, Bundy D (1997) Anthelmintics. A comparative review of their clinical pharmacology. Drugs 53: 769\u2013788","DOI":"10.2165\/00003495-199753050-00004"},{"key":"0882_CR21","doi-asserted-by":"crossref","unstructured":"Doenhoff MJ, Kusel JR, Coles GC, Cioli D (2002) Resistance of Schistosoma mansoni to praziquantel: is there a problem? Trans R Soc Trop Med Hyg 96: 465\u2013469","DOI":"10.1016\/S0035-9203(02)90405-0"},{"key":"0882_CR22","doi-asserted-by":"crossref","unstructured":"Ducharme J, Farinotti R (1996) Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements. Clin Pharmacokinet 31: 257\u2013274","DOI":"10.2165\/00003088-199631040-00003"},{"key":"0882_CR23","unstructured":"Eiam-Ong S (2002) Current knowledge in falciparum malaria\u2013induced acute renal failure. J Med Assoc Thai 85 (Suppl)1: S16\u201324"},{"key":"0882_CR24","doi-asserted-by":"crossref","unstructured":"el-On J, Halevy S, Grunwald MH, Weinrauch L (1992) Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. J Am Acad Dermatol 27: 227\u2013231","DOI":"10.1016\/0190-9622(92)70175-F"},{"key":"0882_CR25","doi-asserted-by":"crossref","unstructured":"Filice C, Di Perri G, Strosselli M, Brunetti E, Dughetti S, Van Thiel DH, Scotti-Foglieni C (1992) Outcome of hepatic amebic abscesses managed with three different therapeutic strategies. Dig Dis Sci 37: 240\u2013247","DOI":"10.1007\/BF01308178"},{"key":"0882_CR26","unstructured":"Fock R, Koch U, Wirtz A, Peters M, Ruf B, Gr\u00fcnewald T (2001) Erste medizinische und antiepidemische Ma\u00dfnahmen bei Verdacht auf virales h\u00e4morrhagisches Fieber. Med Welt 52: 126\u2013132"},{"key":"0882_CR27","doi-asserted-by":"crossref","unstructured":"Freeman CD, Klutman NE, Lamp KC (1997) Metronidazole. A therapeutic review and update. Drugs 54: 679\u2013708","DOI":"10.2165\/00003495-199754050-00003"},{"key":"0882_CR28","unstructured":"Griffin JP (1999) Drug interactions with antimalarial agents. Adv Drug React Toxicol Rev 18: 25\u201343"},{"key":"0882_CR29","doi-asserted-by":"crossref","unstructured":"Hanna RM, Dahniya MH, Badr SS, El-Betagy A (2000) Percutaneous catheter drainage in drug-resistant amoebic liver abscess. Trop Med Int Health 5: 578\u2013581","DOI":"10.1046\/j.1365-3156.2000.00586.x"},{"key":"0882_CR30","doi-asserted-by":"crossref","unstructured":"Harms G, Chehade AK, Douba M, Roepke M, Mouakeh A, Rosenkaimer F, Bienzle U (1991) A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 85: 214\u2013216","DOI":"10.1016\/0035-9203(91)90026-U"},{"key":"0882_CR31","doi-asserted-by":"crossref","unstructured":"Hatz C, Abdulla S, Mull R et al. (1998) Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1\u20135 years. Trop Med Int Health 3: 498\u2013504","DOI":"10.1046\/j.1365-3156.1998.00250.x"},{"key":"0882_CR32","unstructured":"Hoerauf A, Adjei O, B\u00fcttner DW (2002) Antibiotics for the treatment of onchocerciasis and other filarial infections. Curr Opin Invest Drugs 3: 533\u2013537"},{"key":"0882_CR33","doi-asserted-by":"crossref","unstructured":"Hoge CW, Shlim DR, Ghimire M et al. (1995) Placebo-controlled trial of co-trimoxazole for Cyclospora infections among travellers and foreign residents in Nepal. Lancet 345: 691\u2013693","DOI":"10.1016\/S0140-6736(95)90868-4"},{"key":"0882_CR34","doi-asserted-by":"crossref","unstructured":"Holst FG, Hemmer CJ, Kern P, Dietrich M (1994) Inappropriate secretion of antidiuretic hormone and hyponatremia in severe falciparum malaria. Am J Trop Med Hyg 50: 602\u2013607","DOI":"10.4269\/ajtmh.1994.50.602"},{"key":"0882_CR35","doi-asserted-by":"crossref","unstructured":"Horton J (2002) Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations. Curr Opin Infect Dis 15: 599\u2013608","DOI":"10.1097\/00001432-200212000-00008"},{"key":"0882_CR36","doi-asserted-by":"crossref","unstructured":"Irusen EM, Jackson TF, Simjee AE (1992) Asymptomatic intestinal colonization by pathogenic Entamoeba histolytica in amebic liver abscess: prevalence, response to therapy, and pathogenic potential. Clin Infect Dis 14: 889\u2013893","DOI":"10.1093\/clinids\/14.4.889"},{"key":"0882_CR37","doi-asserted-by":"crossref","unstructured":"Jelinek T, Muhlberger N, Harms G et al. (2002) Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis 35: 1047\u20131052","DOI":"10.1086\/342906"},{"key":"0882_CR38","doi-asserted-by":"crossref","unstructured":"Jelinek T, Schulte C, Behrens R et al. (2002) Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis 34: 572\u2013576","DOI":"10.1086\/338235"},{"key":"0882_CR39","doi-asserted-by":"crossref","unstructured":"Karbwang J, Na-Bangchang K (1994) Clinical application of mefloquine pharmacokinetics in the treatment of P falciparum malaria. Fundam Clin Pharmacol 8: 491\u2013502","DOI":"10.1111\/j.1472-8206.1994.tb00830.x"},{"key":"0882_CR40","unstructured":"Kern P, Burchard GD, Dietrich M (1984) Comparative study of oltipraz versus praziquantel for treatment of schistosomiasis with intestinal manifestation in the Gabon (Schistosoma intercalatum and S. haematobium). Tropenmed Parasitol 35: 95\u201399"},{"key":"0882_CR41","doi-asserted-by":"crossref","unstructured":"Khokhani RC, Garud AD, Deodhar KP, Sureka SB, Kulkarni M, Damle VB (1977) Comparative study of tinidazole and metronidazole in amoebic liver abscess. Curr Med Res Opin 5: 161\u2013163","DOI":"10.1185\/03007997709110158"},{"key":"0882_CR42","doi-asserted-by":"crossref","unstructured":"Krause G, Kroeger A (1994) Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. Trans R Soc Trop Med Hyg 88: 92\u201394","DOI":"10.1016\/0035-9203(94)90517-7"},{"key":"0882_CR43","doi-asserted-by":"crossref","unstructured":"Krishna S, White NJ (1996) Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharmacokinet 30: 263\u2013299","DOI":"10.2165\/00003088-199630040-00002"},{"key":"0882_CR44","doi-asserted-by":"crossref","unstructured":"Lefevre G, Looareesuwan S, Treeprasertsuk S et al. (2001) A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg 64: 247\u2013256","DOI":"10.4269\/ajtmh.2001.64.247"},{"key":"0882_CR45","doi-asserted-by":"crossref","unstructured":"Ling J, Baird JK, Fryauff DJ et al. (2002) Randomized, placebo-controlled trial of atovaquone\/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia. Clin Infect Dis 35: 825\u2013833","DOI":"10.1086\/342578"},{"key":"0882_CR46","doi-asserted-by":"crossref","unstructured":"Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB (1999) Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. Am J Trop Med Hyg 60: 533\u2013541","DOI":"10.4269\/ajtmh.1999.60.533"},{"key":"0882_CR47","doi-asserted-by":"crossref","unstructured":"Lumlertgul D, Keoplung M, Sitprija V, Moollaor P, Suwangool P (1989) Furosemide and dopamine in malarial acute renal failure. Nephron 52: 40\u201344","DOI":"10.1159\/000185580"},{"key":"0882_CR48","doi-asserted-by":"crossref","unstructured":"Marschang A, Nothdurft HD, Kumlien S, von Sonnenburg F (1995) Imported rickettsioses in German travelers. Infection 23: 94\u201397","DOI":"10.1007\/BF01833873"},{"key":"0882_CR49","unstructured":"Meremikwu M, Oyo-Ita A (2002) Paracetamol for treating fever in children. Cochrane Database Syst RevCD003676"},{"key":"0882_CR50","doi-asserted-by":"crossref","unstructured":"Mulenga M, Sukwa TY, Canfield CJ, Hutchinson DB (1999) Atovaquone and proguanil versus pyrimethamine\/sulfadoxine for the treatment of acute falciparum malaria in Zambia. Clin Ther 21: 841\u2013852","DOI":"10.1016\/S0149-2918(99)80006-X"},{"key":"0882_CR51","unstructured":"Omari AA, Preston C, Garner P (2002) Artemether-lumefantrine for treating uncomplicated falciparum malaria. Cochrane Database Syst RevCD003125"},{"key":"0882_CR52","doi-asserted-by":"crossref","unstructured":"Pape JW, Verdier RI, Boncy M, Boncy J, Johnson WD (1994) Cyclospora infection in adults infected with HIV. Clinical manifestations, treatment, and prophylaxis. Ann Intern Med 121: 654\u2013657","DOI":"10.7326\/0003-4819-121-9-199411010-00004"},{"key":"0882_CR53","doi-asserted-by":"crossref","unstructured":"Pape JW, Verdier RI, Johnson WD (1989) Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 320: 1044\u20131047","DOI":"10.1056\/NEJM198904203201604"},{"key":"0882_CR54","unstructured":"Pichard E, Traore HA, Keita A, Dembele M, Doumbo O, Pene P (1991) Traitement court de l'amibiase h\u00e9patique par le tinidazole. A propos de 10 cas. Bull Soc Pathol Exot 84: 94\u2013100"},{"key":"0882_CR55","doi-asserted-by":"crossref","unstructured":"Prudhomme L, Loche F, Massip P, Marchou B (2002) Cutaneous larva migras. Med Mal Infect 32: 115\u2013116","DOI":"10.1016\/S0399-077X(01)00329-8"},{"key":"0882_CR56","doi-asserted-by":"crossref","unstructured":"Riddle MS, Jackson JL, Sanders JW, Blazes DL (2002) Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis 34: 1192\u20131198","DOI":"10.1086\/339810"},{"key":"0882_CR57","doi-asserted-by":"crossref","unstructured":"Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, McManus DP (2002) Schistosomiasis. N Engl J Med 346: 1212\u20131220","DOI":"10.1056\/NEJMra012396"},{"key":"0882_CR58","unstructured":"Saconato H, Atallah A (2000) Interventions for treating schistosomiasis mansoni. Cochrane Database Syst RevCD000528"},{"key":"0882_CR59","doi-asserted-by":"crossref","unstructured":"Schlagenhauf P (1999) Mefloquine for malaria chemoprophylaxis 1992\u20131998: a review. J Travel Med 6: 122\u2013133","DOI":"10.1111\/j.1708-8305.1999.tb00843.x"},{"key":"0882_CR60","doi-asserted-by":"crossref","unstructured":"Sharma MP, Rai RR, Acharya SK, Ray JC, Tandon BN (1989) Needle aspiration of amoebic liver abscess. BMJ 299: 1308\u20131309","DOI":"10.1136\/bmj.299.6711.1308"},{"key":"0882_CR61","unstructured":"Simjee AE, Gathiram V, Jackson TF, Khan BF (1985) A comparative trial of metronidazole v. tinidazole in the treatment of amoebic liver abscess. S Afr Med J 68: 923\u2013924"},{"key":"0882_CR62","doi-asserted-by":"crossref","unstructured":"Sowunmi A, Newton CR, Waruiru C, Lightman S, Dunger DB (2000) Arginine vasopressin secretion in Kenyan children with severe malaria. J Trop Pediatr 46: 195\u2013199","DOI":"10.1093\/tropej\/46.4.195"},{"key":"0882_CR63","unstructured":"Squires N (2000) Interventions for treating schistosomiasis haematobium. Cochrane Database Syst RevCD000053"},{"key":"0882_CR64","doi-asserted-by":"crossref","unstructured":"Stephan C, Allwinn R, Brodt HR, Knupp B, Preiser W, Just-Nubling G (2002) Travel-acquired dengue infection: clinical spectrum and diagnostic aspects. Infection 30: 225\u2013228","DOI":"10.1007\/s15010-002-3052-7"},{"key":"0882_CR65","doi-asserted-by":"crossref","unstructured":"Sundar S (2001) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6: 849\u2013854","DOI":"10.1046\/j.1365-3156.2001.00778.x"},{"key":"0882_CR66","doi-asserted-by":"crossref","unstructured":"Sundar S, Agrawal G, Rai M, Makharia MK, Murray HW (2001) Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial. BMJ 323: 419\u2013422","DOI":"10.1136\/bmj.323.7310.419"},{"key":"0882_CR67","doi-asserted-by":"crossref","unstructured":"Sundar S, Jha TK, Thakur CP et al. (2002) Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 347: 1739\u20131746","DOI":"10.1056\/NEJMoa021556"},{"key":"0882_CR68","doi-asserted-by":"crossref","unstructured":"Sundar S, Jha TK, Thakur CP, Mishra M, Singh VR, Buffels R (2002) Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. Am J Trop Med Hyg 66: 143\u2013146","DOI":"10.4269\/ajtmh.2002.66.143"},{"key":"0882_CR69","unstructured":"Tandon A, Jain AK, Dixit VK, Agarwal AK, Gupta JP (1997) Needle aspiration in large amoebic liver abscess. Trop Gastroenterol 18: 19\u201321"},{"key":"0882_CR70","doi-asserted-by":"crossref","unstructured":"Taylor WR, White NJ (2002) Malaria and the lung. Clin Chest Med 23: 457\u2013468","DOI":"10.1016\/S0272-5231(02)00004-7"},{"key":"0882_CR71","doi-asserted-by":"crossref","unstructured":"Thakur CP (2001) A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study. Int J Antimicrob Agents 17: 67\u201370","DOI":"10.1016\/S0924-8579(00)00312-5"},{"key":"0882_CR72","unstructured":"Toma H, Sato Y, Shiroma Y, Kobayashi J, Shimabukuro I, Takara M (2000) Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian J Trop Med Public Health 31: 147\u2013151"},{"key":"0882_CR73","doi-asserted-by":"crossref","unstructured":"Trang TT, Phu NH, Vinh H et al. (1992) Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis 15: 874\u2013880","DOI":"10.1093\/clind\/15.5.874"},{"key":"0882_CR74","doi-asserted-by":"crossref","unstructured":"van Agtmael M, Bouchaud O, Malvy D et al. (1999) The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the tropics to the Netherlands and France. Int J Antimicrob Agents 12: 159\u2013169","DOI":"10.1016\/S0924-8579(99)00070-9"},{"key":"0882_CR75","doi-asserted-by":"crossref","unstructured":"Van Allan RJ, Katz MD, Johnson MB, Laine LA, Liu Y, Ralls PW (1992) Uncomplicated amebic liver abscess: prospective evaluation of percutaneous therapeutic aspiration. Radiology 183: 827\u2013830","DOI":"10.1148\/radiology.183.3.1584941"},{"key":"0882_CR76","doi-asserted-by":"crossref","unstructured":"Verdier RI, Fitzgerald DW, Johnson WD, Pape JW (2000) Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. Ann Intern Med 132: 885\u2013888","DOI":"10.7326\/0003-4819-132-11-200006060-00006"},{"key":"0882_CR77","doi-asserted-by":"crossref","unstructured":"Visser LG, Polderman AM, Stuiver PC (1995) Outbreak of schistosomiasis among travelers returning from Mali, West Africa. Clin Infect Dis 20: 280\u2013285","DOI":"10.1093\/clinids\/20.2.280"},{"key":"0882_CR78","unstructured":"Weber MW, Boker K, Horstmann RD, Ehrich JH (1991) Renal failure is a common complication in non-immune Europeans with Plasmodium falciparum malaria. Trop Med Parasitol 42: 115\u2013118"},{"key":"0882_CR79","doi-asserted-by":"crossref","unstructured":"Wheat J, Sarosi G, McKinsey D et al. (2000) Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 30: 688\u2013695","DOI":"10.1086\/313752"},{"key":"0882_CR80","unstructured":"WHO (2000) Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94 (Suppl): S1\u201390"},{"key":"0882_CR81","doi-asserted-by":"crossref","unstructured":"Winstanley P (2001) Modern chemotherapeutic options for malaria. Lancet Infect Dis 1: 242\u201350","DOI":"10.1016\/S1473-3099(01)00119-0"},{"key":"0882_CR82","unstructured":"Zaat JO, Mank T, Assendelft WJ (2000) Drugs for treating giardiasis. Cochrane Database Syst RevCD000217"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-003-0882-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-003-0882-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-003-0882-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-003-0882-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:11:21Z","timestamp":1558584681000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-003-0882-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,12]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["0882"],"URL":"https:\/\/doi.org\/10.1007\/s00108-003-0882-z","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,12]]}}}